Member access

4-Traders Homepage  >  Shares  >  Nyse  >  West Pharmaceutical Services Inc.    WST   US9553061055

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Sales1 1921 2661 3681 4251 5111 658
Operating income (EBITDA)193219248285315350
Operating profit (EBIT)118142162187211247
Pre-Tax Profit (EBT)92,7109----
Net income75,580,7112131150178
EPS ( $)1,081,151,571,802,052,46
Dividend per Share ( $)0,35-0,390,430,47-
Yield0,66%-0,75%0,83%0,90%-
Announcement Date02/16/2012
12:00pm
02/21/2013
12:15pm
02/20/2014
12:00pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Debt258-----
Finance------
Operating income (EBITDA)193219248285315350
Leverage
(Debt/EBITDA)
1,33x-----
Capital Expenditure95,4-----
Book Value Per Share (BVPS)------
Cash Flow per Share--3,09 $3,29 $3,54 $-
Announcement Date02/16/2012
12:00pm
02/21/2013
12:15pm
02/20/2014
12:00pm
---
Balance Sheet Analysis
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 3 703 M$ -
Entreprise Value (EV) - 3 703 M$
Valuation 2014e 2015e
PER (Price / EPS) 29,0x 25,4x
Capitalization / Revenue 2,60x 2,45x
EV / Revenue - -
EV / EBITDA - -
Yield (DPS / Price) 0,83% 0,90%
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 13,2% 14,0%
operating Leverage (Delta EBIT / Delta Sales) 3,73x 2,07x
Net Margin (Net Profit / Revenue) 9,18% 9,93%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 12,6% -
Rate of Dividend 23,9% 22,9%
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   - -
Cash Flow / Sales (Taux d'autofinancement) 16,4% 16,7%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
EPS & Dividend
Dynamic quotes  
ON
| OFF